4-Methylpiperazine-1-ethylamine → HCID 131735860, compound

HRID 2206402Notes

Reaction equation

[Cl:1][C:2]1[C:3]([F:42])=[C:4]([C@@H:8]2[C@:12]([C:15]3[CH:20]=[CH:19][C:18]([Cl:21])=[CH:17][C:16]=3[F:22])([C:13]#[N:14])[C@H:11]([CH2:23][C:24]([CH3:27])([CH3:26])[CH3:25])[NH:10][C@H:9]2[C:28]([NH:30][C:31]2[CH:39]=[CH:38][C:34]([C:35](O)=[O:36])=[CH:33][C:32]=2[O:40][CH3:41])=[O:29])[CH:5]=[CH:6][CH:7]=1.[CH3:43][N:44]1[CH2:49][CH2:48][N:47]([CH2:50][CH2:51][NH2:52])[CH2:46][CH2:45]1>>[ClH:1].[CH3:41][O:40][C:32]1[CH:33]=[C:34]([C:35](=[O:36])[NH:52][CH2:51][CH2:50][N:47]2[CH2:48][CH2:49][N:44]([CH3:43])[CH2:45][CH2:46]2)[CH:38]=[CH:39][C:31]=1[NH:30][C:28]([C@H:9]1[C@H:8]([C:4]2[CH:5]=[CH:6][CH:7]=[C:2]([Cl:1])[C:3]=2[F:42])[C@:12]([C:15]2[CH:20]=[CH:19][C:18]([Cl:21])=[CH:17][C:16]=2[F:22])([C:13]#[N:14])[C@H:11]([CH2:23][C:24]([CH3:27])([CH3:26])[CH3:25])[NH:10]1)=[O:29]

Participants

Reactant 2

HCID 702844-Methylpiperazine-1-ethylamine

HCID 53358942Idasanutlin

Product 1

HCID 131735860HCID 131735860, compound

Procedure

In a manner similar to the method described in Example 14, 4-((2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-neopentylpyrrolidine-2-carboxamido)-3-methoxybenzoic acid (prepared as described in US20100152190A1) was reacted with 2-(4-methylpiperazin-1-yl)ethanamine to give (2R,3S,4R,5S)-4-(4-chloro-2-fluoro-phenyl)-3-(3-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carboxylic acid {2-methoxy-4-[2-(4-methyl-piperazin-1-yl)-ethylcarbamoyl]-phenyl}-amide, hydrochloride. MS (ES+) m/z calcd. for C38H45Cl2F2N6O3: [(M+H)+]: 741. found: 741.

Sources & evidence

ORD record: ord-4840fe448af747f19dd4cdb139b317fa
Source dataset: uspto-grants-2016_06
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US09371280B2

Reaction notes

Loading…